Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  radium ra 223 dichloride
Find trials that include:  Any drugs shown
Results 1-13 of 13 for your search:
Start Over
Observational Study for the Evaluation of Long-term Safety of Radium-223 Used for the Treatment of Metastatic Castration Resistant Prostate Cancer
Status: Active
Phase: Phase IV
Type: Natural history/Epidemiology
Age: 18 and over
Trial IDs: 16913, NCI-2014-02038, NCT02141438
Radium Ra 223 Dichloride and Enzalutamide in Treating Patients with Metastatic Prostate Cancer That Is Resistant to Antihormone Therapy
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: HCI68770, NCI-2014-01823, 68770, NCT02199197
Radium Ra 223 Dichloride in Reducing Pain in Patients with Symptomatic Metastatic Hormone-Resistant Prostate Cancer
Status: Active
Phase: Phase II
Type: Supportive care
Age: 18 and over
Trial IDs: 14-098, NCI-2014-02542, c13-124, NCT02278055
Radium Ra 223 Dichloride in Treating Patients with Metastatic Castration-Resistant Prostate Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 14-375, NCI-2015-00625, ONC-2013-119, NCT02346526
Radium Ra 223 Dichloride, Hormone Therapy, and Denosumab in Treating Patients with Hormone-Positive, Bone-Dominant Metastatic Breast Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2014-0508, NCI-2015-00508, NCT02366130
Biomarker Expression in Blood and Tissue Samples from Patients with Hormone Resistant Prostate Cancer Bone Metastasis Receiving Radium Ra 223 Dichloride
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis
Age: 18 and over
Trial IDs: Pro00053925, NCI-2015-02118, NCT02204943
Radium Ra 223 Dichloride with Pazopanib Hydrochloride or Sorafenib Tosylate in Treating Patients with Metastatic Kidney Cancer and Bone Metastases
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 18 and over
Trial IDs: 14-523, NCI-2015-00915, ONC-2014-092, NCT02406521
Carbon-11 Acetate PET/CT Imaging in Evaluating Response to Radium Ra 223 Dichloride Therapy in Patients with Hormone-Resistant Metastatic Prostate Cancer
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Age: 18 and over
Trial IDs: UPCC 02816, NCI-2016-00612, NCT02715583
Start Over